ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures

May 17, 2013

Prostatectomy Improves Outcome In Some Men

August 29, 2008

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started

February 18, 1983

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998